BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22586290)

  • 1. Georg Ohm and the changing character of aortic stenosis: it's not your grandfather's oldsmobile.
    Carabello BA
    Circulation; 2012 May; 125(19):2295-7. PubMed ID: 22586290
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis.
    Lindman BR; Zajarias A; Madrazo JA; Shah J; Gage BF; Novak E; Johnson SN; Chakinala MM; Hohn TA; Saghir M; Mann DL
    Circulation; 2012 May; 125(19):2353-62. PubMed ID: 22447809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reply: To PMID 24837446.
    Chen H; Weng Z
    Urology; 2014 Jul; 84(1):56. PubMed ID: 24837448
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment.
    Hanno P
    Urology; 2014 Jul; 84(1):56. PubMed ID: 24837446
    [No Abstract]   [Full Text] [Related]  

  • 5. How long can we leave patients with pulmonary arterial hypertension on oral drug monotreatment?
    Ogawa A; Matsubara H
    Circ J; 2012; 76(5):1089-90. PubMed ID: 22466634
    [No Abstract]   [Full Text] [Related]  

  • 6. "Out of the blue"-safety and efficacy of pulmonary hypertension treatment in childhood*.
    Kraemer U; Wildschuth E; Tibboel D
    Pediatr Crit Care Med; 2014 May; 15(4):377-8. PubMed ID: 24801422
    [No Abstract]   [Full Text] [Related]  

  • 7. [The prescription].
    Rabe J
    MMW Fortschr Med; 2013 Jan; 155(1):28. PubMed ID: 23573716
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic Inhibition of cGMP phosphodiesterase 5A improves diabetic cardiomyopathy: a randomized, controlled clinical trial using magnetic resonance imaging with myocardial tagging.
    Giannetta E; Isidori AM; Galea N; Carbone I; Mandosi E; Vizza CD; Naro F; Morano S; Fedele F; Lenzi A
    Circulation; 2012 May; 125(19):2323-33. PubMed ID: 22496161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. eComment. Further study needed.
    Quraishi NN; Lemon TI; Black LF
    Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):968. PubMed ID: 24243943
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination therapy with an endothelin-1 receptor antagonist (bosentan) and a phosphodiesterase V inhibitor (sildenafil) for the management of severe digital ulcerations in systemic sclerosis.
    Moinzadeh P; Hunzelmann N; Krieg T
    J Am Acad Dermatol; 2011 Sep; 65(3):e102-e104. PubMed ID: 21839301
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oral sildenafil for pulmonary hypertension in neonates].
    Gutiérrez Nicolás F; Viña Romero MM; González Carretero P; Merino Alonso J
    Farm Hosp; 2011; 35(3):157-8. PubMed ID: 21439880
    [No Abstract]   [Full Text] [Related]  

  • 12. Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats.
    Choi DE; Jeong JY; Lim BJ; Chung S; Chang YK; Lee SJ; Na KR; Kim SY; Shin YT; Lee KW
    Am J Physiol Renal Physiol; 2009 Aug; 297(2):F362-70. PubMed ID: 19474186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons from the viagra study: methodological challenges in recruitment of older and minority heterosexual men for research on sexual practices and risk behaviors.
    Jones SG; Pat Patsdaughter CA; Martinez Cardenas VM
    J Assoc Nurses AIDS Care; 2011; 22(4):320-9. PubMed ID: 21216626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
    Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
    Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A neurohypophysial end game: spreading excitation with sildenafil.
    Armstrong WE
    J Physiol; 2007 Oct; 584(Pt 1):3. PubMed ID: 17717007
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P; Parry G; Dark JH; Macgowan GA
    J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma and viagra: an unexpected connection.
    Mitra D; Robinson KC; Fisher DE
    Pigment Cell Melanoma Res; 2011 Feb; 24(1):16-8. PubMed ID: 21290790
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac anti-remodelling effects of phosphodiesterase type 5 inhibitors: afterload-(in)dependent?
    Kuhn M
    Cardiovasc Res; 2009 Apr; 82(1):4-6. PubMed ID: 19221131
    [No Abstract]   [Full Text] [Related]  

  • 19. Postcoital vomiting after taking sildenafil?
    Lamb M; Brahm N; Fox MD
    J Fam Pract; 2013 Feb; 62(2):61-2. PubMed ID: 23405374
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous sildenafil as a preconditioning drug against hemodynamic consequences of warm ischemia-reperfusion on the kidney.
    Lledo-Garcia E; Subira-Rios D; Ogaya-Pinies G; Tejedor-Jorge A; Cañizo-Lopez JF; Hernandez-Fernandez C
    J Urol; 2011 Jul; 186(1):331-3. PubMed ID: 21600605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.